Skip to main content

Table 1 Datation regarding the MR imaging pps

From: The safety and efficacy of Glubran 2 as biliostatic agent in liver resection

  mCRC patients (no.=205) Control patients (no.=113) P value
Demographics
 Gender Men 89 (43.4%) Men 64 (56.6%) 0.89
Women 116 (56.6%) Women 49 (43.4%) 0.89
 Age Mean, 56 years Mean, 48 years 0.74
Range, 33-80 years Range, 35-78 years
Primary cancer site
 Colon 94 (45.9%) 52 (46%) 0.92
 Rectum 111 (54.1%) 61 (54%) 0.92
History of chemotherapy 205 (100 %) 113 (100%) 0.99
Chemotherapy protocol mFOLFOX6 (5-fluorouracil, leucovorin, oxaliplatin) plus bevacizumab 205 (100%) mFOLFOX6 (5-fluorouracil, leucovorin, oxaliplatin) plus bevacizumab 113 (100%)  
Liver metastases
 Number 1075 452  
mean 4 per patient mean 5 per patient
range 1-7 per patient range 2-6 per patient
 Largest diameter mean 32 mm mean 28 mm  
range 8-64 mm range 10-54 mm
Complications
 Biloma 27 (13%) 18 (16%) 0.054
 Bile leakage 2 (1%) 3 (2.6%) 0.001